Quetiapine-induced bradycardia without qt interval prolongation in an elderly woman

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 11, Issue 4, 2009, Pages 172-173

  Janse, André ^a   Marijnissen, Radboud M ^b  

^a Department of Rheumatology   (Netherlands)

^b De Gelderse Roos Mental Health Care ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; QUETIAPINE;

ADULT; ATRIOVENTRICULAR BLOCK; BLOOD PRESSURE; BRADYCARDIA; CASE REPORT; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; EXERCISE; FATIGUE; FEMALE; HEART ATRIOVENTRICULAR NODE; HEART VENTRICLE EXTRASYSTOLE; HOLTER MONITORING; HUMAN; LETTER; PARANOID SCHIZOPHRENIA; PULSE RATE; QT PROLONGATION; SICK SINUS SYNDROME; SINUS BRADYCARDIA; STANDING;

EID: 77950623157     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.08l00683     Document Type: Letter

References (8)

1. Tran KT, Golden P, Lark T, et al. Bradycardia at low doses of risperidone [letter]. Am J Psychiatry. 2004;161(12):2325-2326.
2. Goyal RS, Goyal SB. Symptomatic bradyarrythmia secondary to risperidone [letter]. Am J Psychiatry. 2003;160(12):2243.
3. Lee TW, Tsai SJ, Hwang J P. Severe cardiovascular side effects of olanzapine in an elderly patient: case report. Int J Psychiatry Med. 2003;33(4):399-401.
4. Pitner JK, Mintzer JE, Pennypacker LC, et al. Efficacy and adverse effects of clozapine in four elderly psychotic patients. J Clin Psychiatry. 1995;56(5):180-185.
5. Stollberger C, Huber JO, Finsterer J. Antipsychotic drugs and QT prolongation. Int Clin Psychopharmacol. 2005;20(5):243-251.
6. Magyar J, Banyasz T, Bagi Z, et al. Electrophysiological effects of risperidone inmammalian cardiac cells. Naunyn Schmiedebergs Arch Pharmacol. 2002;366(4):350-356.
7. Gareri P, De Fazio, P, De Fazio S, et al. Adverse effects of atypical antipsychotics in the elderly: a review. Drugs Aging. 2006;23(12): 937-956.
8. Naranjo CA, Shear NH, Lanctot KL. Advances in the diagnosis of adverse drug reactions. J Clin Pharmacol. 1992;32(10):897-904.